News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Douglas Teixeira Leffa, MD, PhD

Douglas Teixeira Leffa, MD, PhD

Dr Leffa is a psychiatry resident at the University of Pittsburgh Medical Center.

Articles by Douglas Teixeira Leffa, MD, PhD

Psychiatric Times with heart

What We Love About Psychiatry: Reflections From the Field

ByJohn J. Miller, MD,Allison S. Baker, MD,Douglas Teixeira Leffa, MD, PhD,Timothy Wilens, MD,Benjamin E. Yerys, PhD,Jennie Byrne, MD, PhD,Elysia Davis, PhD,Benjamin Hankin, PhD,Gary W. Small, MD

February 14th 2026

Adult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis

ByDouglas Teixeira Leffa, MD, PhD,Heidi Anne Duerr, MPH

January 22nd 2026

Douglas Leffa, MD, PhD, shares highlights from a poster at the APSARD conference examining severity and age of diagnosis.

Latest Updated Articles

Trending on Psychiatric Times

Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia

Treating Cannabis Addiction and Withdrawal: Latest Clinical Data

New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD

Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy

Consensus Guidelines for IV Ketamine: Safe Clinical Practice